Moxidectin for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Moxidectin is a macrocyclic lactone dewormer used in horses and ponies to treat certain internal parasites. In the U.S., it is sold as an oral gel product, including Quest Gel and the combination product Quest Plus Gel. Quest Plus adds praziquantel, which broadens coverage to include tapeworms.

Moxidectin is valued because it has activity against adult small strongyles and encysted cyathostome larvae, which are important parasites in many adult horses. That said, deworming plans are no longer based on routine rotation alone. Current equine parasite-control guidance emphasizes fecal egg counts, herd risk, age, and season when deciding whether moxidectin is the right choice.

This medication has a narrower safety margin than some other dewormers, so accurate body-weight estimation matters. Product labeling and equine guidance also warn against use in foals under 6 months of age and in sick, debilitated, or underweight horses unless your vet specifically advises otherwise.

Moxidectin is used to treat and control several common equine parasites. Labeled uses include large strongyles, small strongyles, encysted cyathostomes, pinworms, hairworms, large-mouth stomach worms, bots, and ascarids. In combination with praziquantel, it is also labeled for tapeworms.

In practice, your vet may consider moxidectin when a horse needs coverage for encysted small strongyles, or when a seasonal parasite-control plan calls for a product with that spectrum. AAEP guidance supports more targeted deworming rather than fixed every-8-week schedules, because resistance patterns have changed over time.

Moxidectin is not the right fit for every horse. Young foals, thin horses, and horses with illness may need a different approach. Your vet may also recommend a different product if fecal testing, age, farm history, or local resistance patterns suggest another option would be a better match.

For labeled equine oral gel products, the standard dose is 0.4 mg/kg by mouth as a single dose. For combination moxidectin/praziquantel gel, the labeled dose is 0.4 mg/kg moxidectin plus 2.5 mg/kg praziquantel as a single oral dose. Syringes are weight-calibrated, so your vet will want the horse's weight estimated as accurately as possible before dosing.

Because moxidectin has a tighter safety margin than some other dewormers, do not guess high on body weight. Overdosing is a bigger concern in small horses, ponies, minis, underweight horses, and debilitated horses. Product labeling also states these products should be used only in horses and ponies 6 months of age and older.

Deworming frequency should be individualized. AAEP guidelines recommend using fecal egg counts once or twice yearly to help classify horses as low, medium, or high shedders, and to avoid unnecessary treatment. Your vet may recommend moxidectin only at certain times of year, or may choose another dewormer based on age, parasite risk, and farm management.

Most horses tolerate labeled moxidectin well when it is dosed correctly. In approval studies, adverse reactions were uncommon at labeled doses. Still, side effects can happen, especially if a horse is overdosed, is very small for the syringe setting, or is sick, thin, or otherwise more vulnerable.

Signs of toxicity or intolerance may include depression, dullness, weakness, incoordination, trembling, drooping lower lip, trouble standing, or recumbency. Severe neurologic signs are more likely with overdose. If your horse seems unusually quiet, wobbly, or weak after treatment, see your vet immediately.

Some horses may also have mild, short-lived digestive upset or changes in manure after deworming, especially if they carry a heavy parasite burden. If your horse develops colic signs, marked diarrhea, worsening lethargy, or neurologic changes, contact your vet right away rather than waiting to see if it passes.

There are no widely cited routine drug interactions that pet parents commonly manage at home with equine oral moxidectin, but that does not mean interactions are impossible. The bigger safety issue is often the horse's condition and dosing accuracy, not a specific day-to-day medication conflict.

Tell your vet about all medications, supplements, recent dewormers, and any prior reactions before using moxidectin. This is especially important if your horse is receiving other treatments that can affect the nervous system, is being treated for a serious illness, or has ongoing weight loss, diarrhea, or poor body condition.

Your vet may also adjust the parasite-control plan if your horse was recently dewormed with another product, if there is concern for resistance, or if the horse is in a higher-risk group such as a young foal or a debilitated adult. When in doubt, bring the product box or a photo of the label to your appointment.